Earlier this week, pharmaceutical company Bristol-Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has granted a priority review for Ipilimumab, an i...

HILLSBOROUGH, N.J.—The recent debut of “The Big C” on Showtime has placed some of Hollywood’s spotlight on melanoma, the deadliest form of skin canc...

The Melanoma Research Foundation is proud to announce new research funding opportunities for medical students.  Approximately five research grants will be awarded, all...

The Melanoma Research Foundation (MRF) has partnered with UVSunSense™ to promote sun safety.   The UVSunSense™ wristband has a special coating&nb...

The Melanoma Research Foundation recently launched a public service announcement (PSA) to support efforts to find a cure for melanoma. The PSA features MaryAnn, who be...

-Tan tax in health care legislation begins July 1-  HILLSBOROUGH, N.J.—July 1 marks the beginning of a new 10 percent federal tax instituted on indoor tanning se...

Dr. Lynn Schuchter, chief of hematology/oncology at the University of Pennsylvania Abramson Cancer Center and co-chair of the MRF’s scientific advisory committee, spo...

Dr. David E. Fisher, M.D., Ph.D., a member of the Melanoma Research Foundation’s scientific advisory committee and chairman of dermatology at Massachusetts General Ho...

Recently, health reporter Liz Szabo of USA Today spoke with the MRF’s executive director, Tim Turnham, about some of the latest developments in melanoma research pres...

Dr. Lynn Schuchter offers insights into how new developments will impact treatment options for patients. Dr. Lynn Schuchter, chief of hematology/oncology at the University ...

On June 8, the Melanoma Research Foundation (MRF) joined Cosmopolitan at its Practice Safe Sun Awards in New York City to educate women on the connection between UV-exposur...